Barometer Capital Management’s AstraZeneca AZN Stock Holding History

Barometer Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,450	Closed	-$332K	–	182
2023 Q3	$332K	Buy	+2,450	New	+$335K	0.1%	85
2023 Q2	–	Sell	-18,100	Closed	-$2.51M	–	131
2023 Q1	$2.51M	Buy	+18,100	New	+$2.44M	0.64%	48

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Barometer Capital Management's AZN Position: Q4 2023 in Review

Barometer Capital Management sold out of AstraZeneca (AZN) in Q4 2023, closing a stake of 2,450 shares — an estimated $332K sold.

Barometer Capital Management first reported a position in AZN in Q1 2023 and held it in 2 quarters. The position peaked at $2.51M in Q1 2023. 1,130 funds tracked by Wall St. Rank hold AZN as of Q4 2023.

Barometer Capital Management reported no remaining AstraZeneca position as of Q4 2023 after selling out during the quarter.
Barometer Capital Management sold 2,450 AstraZeneca shares in Q4 2023, an estimated $332K.
Barometer Capital Management first reported a position in AstraZeneca in Q1 2023 and held it in 2 quarters.
Barometer Capital Management's AstraZeneca position peaked at $2.51M in Q1 2023.
1,130 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2023.

Based on Barometer Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.